Iron deficiency anaemia
Iron deficiency anaemia is the most common cause of anaemia. Symptoms are related to the overall decrease in number of red blood cells and/or level of haemoglobin. The most common signs and symptoms include:
- feeling of tiredness, fatigue
- lack of energy
Symptoms that are more unique to iron deficiency and that may appear as iron stores in the body are increasingly depleted may include brittle or spoon-shaped nails, swollen or sore tongue, cracks or ulcers at the corners of the mouth, or a craving to eat unusual non-food substances such as ice or dirt (also known as ‘pica’).
Iron is an essential trace element and is necessary for the production of healthy red blood cells (RBCs). It is one component of haem, a part of haemoglobin, the protein in RBCs that binds to oxygen and enables RBCs to transport oxygen throughout the body. If not enough iron is taken in compared to what is needed by the body, then iron that is stored in the body begins to be used up. If iron stores are depleted, fewer red blood cells are made and they have decreased amounts of haemoglobin in them resulting in anaemia. Some of the causes of iron deficiency include:
- Bleeding — if bleeding is excessive or occurs over a period of the time (chronic), the body may not replace sufficient iron or have enough stored iron to produce enough haemoglobin and/or red blood cells to replace what is lost. In women, iron deficiency may be due to heavy menstrual periods, but in older women and in men, the bleeding is usually from disease of the intestines such as ulcers, polyps and cancer.
- Dietary deficiency — iron deficiency may be due simply to not eating enough iron in the diet. In children and pregnant women especially, the body needs more iron. Pregnant and nursing women frequently develop this deficiency since the baby requires large amounts of iron for growth. Lack of iron can lead to low birth weight babies and premature delivery. Pre-pregnant and pregnant women are commonly prescribed iron supplements to prevent these complications. Newborns who are nursing from deficient mothers tend to have iron deficiency anaemia as well.
- Absorption problem — certain conditions affect the absorption of iron from food in the gastrointestinal (GI) tract and over time can result in anaemia. These include, for example, coeliac disease and Crohn’s disease.
Laboratory tests
Initial blood tests typically include a full blood count (FBC). Results may show:
- Haemoglobin (Hb) — may be normal early in the disease but will decrease as anaemia worsens
- Red blood cell indices — early on, the RBCs may be a normal size and colour (normocytic, normochromic) but as the anaemia progresses, the RBCs become smaller (microcytic) and paler (hypochromic) than normal.
- Average size of RBCs (MCV) — may be decreased
- Average amount of Hb in RBCs (MCH) — may be decreased
- Increased variation in the size of RBCs (red cell distribution width (RDW))
A blood film examination may reveal RBCs that are smaller and paler than normal as well as RBCs that vary in size (anisocytosis) and shape (poikilocytosis).
If your doctor suspects that your anaemia is due to iron deficiency, s/he may run several follow-up tests to confirm the iron deficiency. These may include:
- Serum iron — the level of iron in your blood; the result is usually decreased but is more reflective of recent iron intake rather than the body's true iron stores.
- Ferritin — reflects the amount of stored iron in your body and is usually low. It is considered to be the most specific for identifying iron deficiency anaemia, unless infection or inflammation are present.
- Transferrin and Total iron-binding capacity (TIBC) — measurement of the protein that carries iron through the blood will be increased.
If the iron deficiency is thought to be due to abnormal blood loss, such as chronic bleeding from the gastrointestinal (GI) tract, then other tests and procedures may be performed. Laboratory tests that may be able to detect GI bleeding are:
- Faecal occult blood test (FOB)
- Faecal immunochemical test (FIT)
A test for Helicobacter pylori may detect a bacterium that can cause ulcers in the GI tract that may be a cause of chronic bleeding. If any of these tests are positive or if it is strongly suspected that a GI bleed exists, then procedures such as endoscopy or colonoscopy may be done to find the location of the bleeding so that it can be treated.
Treatment of iron deficiency typically involves iron supplements. However, if iron-deficiency is suspected to result from abnormal blood loss, further testing is often required to determine the reason for the bleeding. When the underlying cause is found and treated, then the anaemia usually resolves.
Pernicious anaemia
Pernicious anaemia is a condition in which the body does not make enough of a substance called ‘intrinsic factor’. Intrinsic factor is a protein produced by parietal cells in the stomach that binds to vitamin B12 and allows it to be absorbed from the small intestine. Vitamin B12 is important in the production of red blood cells (RBCs). Without enough intrinsic factor, the body cannot absorb vitamin B12 from the diet and cannot produce enough normal RBCs, leading to anaemia. In addition to lack of intrinsic factor, other causes of vitamin B12 deficiency and anaemia include dietary deficiency and conditions that affect absorption of the vitamin from the small intestine such as surgery, certain drugs, digestive disorders (coeliac disease, Crohn’s disease), and infections. Of these, pernicious anaemia is the most common cause of symptoms.
Vitamin B12 deficiency can result in general symptoms of anaemia as well as nerve problems. These may include:
- weakness or fatigue
- lack of energy
- numbness and tingling that start first in the hands and feet
Additional symptoms may include muscle weakness, slow reflexes, loss of balance and unsteady walking. Severe cases can lead to confusion, memory loss, depression and/or dementia.
Folic acid is another B vitamin and deficiency in this vitamin may also lead to anaemia. Folic acid, also known as folate, is found in many foods, especially in green, leafy vegetables. Folic acid is added to most grain products so a deficiency in folic acid is rarely seen in Australia today. Folic acid is needed during pregnancy for normal development of the brain and spinal cord. It is important for women considering pregnancy to take folate supplements before they get pregnant and during pregnancy to make sure they are not folate deficient. Folate deficiency early in pregnancy can cause problems in the development of the brain and spinal cord of the baby.
Anaemias resulting from vitamin B12 or folate deficiency are sometimes referred to as ‘macrocytic’ or ‘megaloblastic’ anaemia because red blood cells tend to be larger than normal. A lack of these vitamins does not allow RBCs to grow and then divide as they normally would during development, which leads to their large size. This leads to a reduced number of abnormally large RBCs and anaemia.
Laboratory tests
Symptoms of anaemia will usually be investigated initially with a full blood count (FBC) and White blood Cell differential. In pernicious anaemia or vitamin B12 deficiency, these usually reveal:
- A low haemoglobin level
- For red cell indices, the mean cell volume (MCV), which is the average size of RBCs, is often high.
- A blood film examination will reveal red blood cells that are abnormally large.
Folic acid deficiency can cause the same pattern of changes in haemoglobin and red cell size as vitamin B12 deficiency. If the cause of your anaemia is thought to be due to pernicious anaemia or dietary deficiency of B12 or folate, additional tests are usually done to make the diagnosis. Some of these include:
- Vitamin B12 level — blood level may be low when deficient in B12
- Folic acid level — blood level may be low if deficient in this B vitamin
- Methylmalonic acid (MMA) — may be high with vitamin B deficiency
- Homocysteine — may be high with either folate or vitamin B deficiency
- Reticulocyte count — is usually low
- Antibodies to intrinsic factor or parietal cell antibodies — may be present in pernicious anaemia
Sometimes a bone marrow aspiration may be performed. This may reveal larger than normal sizes in the cells that eventually mature and become RBCs (precursors).
Treatment in these conditions involves supplementation with the vitamin that is deficient. If the cause of deficiency is the inability to absorb the vitamin from the digestive tract, then the vitamin may be given as injections. Treatment of underlying causes such as a digestive disorder or infection may help to resolve the anaemia.
For more on this, see the article on Vitamin B12 and folate deficiency.
Aplastic anaemia
Aplastic anaemia is a rare disease, caused by a decrease in the number of all types of blood cells produced by the bone marrow. Normally, the bone marrow produces a sufficient number of new red blood cells (RBCs), white blood cells (WBCs) and platelets for normal body function. Each type of cell enters the blood stream, circulates and then dies within a certain time frame. For example, the normal lifespan of RBCs is about 120 days. If the bone marrow is not able to produce enough blood cells to replace those that die, a number of symptoms, including those due to anaemia, may result.
Symptoms of aplastic anaemia can appear abruptly or can develop more slowly. Some general symptoms that are common to different types of anaemia may appear first and are due to the decrease in number of RBCs. These include:
- feeling of tiredness, fatigue
- lack of energy
Some additional signs and symptoms that occur with aplastic anaemia include those due to decreased platelets:
- prolonged bleeding
- frequent nosebleeds
- bleeding gums
- easy bruising
and due to a low white blood cell count (WBC):
- increased number and severity of infections
Causes of aplastic anaemia usually have to do with damage to the stem cells in the bone marrow that are responsible for blood cell production. Some factors that may be involved with bone marrow damage and that can lead to aplastic anaemia include:
- exposure to toxic substances such as arsenic, benzene or pesticides
- cancer therapy (radiation or chemotherapy)
- autoimmune disorders such as lupus or rheumatoid arthritis
- viral infections such as hepatitis, EBV, HIV, CMV, or parvovirus B19
Rarely, aplastic anaemia is due to an inherited (genetic) disorder such as Fanconi anaemia. For more on this condition, see the Faconi Anemia Research Fund.
Laboratory tests
The initial test for anaemia, the full blood count (FBC), may reveal many abnormal results.
- Haemoglobin and/or haematocrit may be low.
- RBC and WBC counts are low.
- Platelet count is low.
- Red blood cell indices are usually normal.
- The differential white blood count shows a decrease in most types of cells but not lymphocytes.
Some additional tests that may be performed to help determine the type and cause of anemia include:
- Reticulocyte count — result is usually low.
- Erythropoietin — usually increased in aplastic anaemia.
- A bone marrow aspiration will show a decrease in the number of all types of mature cells.
- Tests for infections such as hepatitis, EBV, CMV, parvovirus B19 help to determine the cause.
- Test for arsenic (a heavy metal) and other toxins
- Iron tests or tests for vitamin B12 may be done to rule out other causes.
- Antibody tests such as ANA to determine if the cause is autoimmune disease.
A physical examination or complete medical history may reveal possible causes for aplastic anaemia such as exposure to toxins or certain drugs (for example, chloramphenicol) or prior treatment for cancer. Some cases of aplastic anaemia are temporary while others have lasting damage to the bone marrow. Treatment depends on the cause. Reducing or eliminating exposure to certain toxins or drugs may help resolve the condition. Medications may be given to stimulate bone marrow production, to treat infections or to suppress the immune system in cases of autoimmune disorders. Blood transfusions and a bone marrow transplant may be needed in severe cases.
Haemolytic anaemia
Rarely, anaemia is due to problems that cause the red blood cells (RBCs) to die or be destroyed prematurely. Normally, red cells live in the blood for about 4 months. In haemolytic anaemia, this time is shortened, sometimes to only a few days. The bone marrow is not able to produce new RBCs quickly enough to replace those that have been destroyed, leading to a decreased number of RBCs in the blood, which in turn leads to a diminished capacity to supply oxygen to tissues throughout the body. This results in the typical symptoms of anaemia including:
- weakness and/or fatigue
- lack of energy
- Depending on the cause, different forms of haemolytic anaemia can be chronic, developing and lasting over a long period or lifetime, or may be acute. The various forms can have a wide range of signs and symptoms.
See the discussions of the various types below for more on this.
The different causes of haemolytic anaemia fall into two main categories:
- Inherited forms in which a gene or genes are passed from one generation to the next that result in abnormal RBCs or haemoglobin
- Acquired forms in which some factor other than inherited results in the early destruction of RBCs
Inherited haemolytic anaemia
Two of the most common causes of inherited haemolytic anaemia are sickle cell anaemia and thalassaemia:
- Sickle cell anaemia can cause minor difficulties as the ‘trait’ (when you carry one mutated gene from one of your parents), but severe clinical problems as the ‘disease’ (when you carry two mutated genes, one from each of your parents). The red blood cells are misshapen, unstable (leading to haemolysis) and can block blood vessels, causing pain and anaemia. Screening is usually done on newborns – particularly those of African descent. Sometimes screening is done prenatally on a sample of amniotic fluid. Follow-up tests for haemoglobin variants may be performed to confirm a diagnosis. Treatment is usually based on the type, frequency and severity of symptoms.
- Thalassemia is a hereditary abnormality of haemoglobin production and results in small red blood cells that resemble those seen in iron deficiency. In its most severe form, the red cells have a shortened life span. In milder forms, anaemia is usually mild or absent, and the disease may be detected by finding small blood cells on a routine FBC. This genetic disease is found frequently in people of Mediterranean, African and Asian heritage. The defect in production may involve one of two components of haemoglobin called the alpha and beta protein chains. The disease is defined as alpha thalassaemia or beta thalassaemia accordingly. The "beta minor" form (sometimes called beta thal trait, as with sickle cell) occurs when a person inherits half normal genes and half beta thalassemia genes. It causes a mild anaemia and no symptoms. The "beta major" form (due to inheriting two beta thalassaemia genes and also called Cooley’s anaemia) is more severe and may result in growth problems, jaundice, and severe anaemia.
Other less common types of inherited forms of haemolytic anaemia include:
- Hereditary spherocytosis — results in abnormally shaped RBCs that may be seen on a blood smear
- Hereditary elliptocytosis — another cause of abnormally shaped RBCs seen on a blood film examination
- Glucose-6-phospate dehydrogenase (G6PD) deficiency — G6PD is an enzyme that is necessary for RBC survival. Its deficiency may be diagnosed with a test for its activity.
- Pyruvate kinase deficiency — Pyruvate kinase is another enzyme important for RBC survival and its deficiency may also be diagnosed with a test for its activity.
Laboratory tests
Since some of these inherited forms may have mild symptoms, they may first be detected on a routine FBC and blood film examination, which can reveal various abnormal results that give clues as to the cause. Follow-up tests are then usually performed to make a diagnosis. Some of these include:
- Tests for haemoglobin variants such as haemoglobin electrophoresis
- DNA analysis — not routinely done but can be used to help diagnose haemoglobin variants, thalassaemia, and to determine carrier status.
- G6PD test — to detect deficiency in this enzyme
- Flow cytometry detection of abnormal or missing red cell membrane proteins — detects RBCs that are more fragile than normal, which may be found in hereditary spherocytosis.
These genetic disorders cannot be cured but often the symptoms resulting from the anaemia may be alleviated with treatment as necessary.
Acquired haemolytic anaemia
Some of the conditions or factors involved in acquired forms of haemolytic anaemia include:
- Autoimmune disorders — a condition in which the body produces antibodies against its own red blood cells. It is not understood why this may happen.
- Transfusion reaction — result of blood donor-recipient incompatibility. This occurs very rarely but when it does, it can have some serious complications. For more on this, see the Blood banking article.
- Mother-baby blood group incompatibility — may result in haemolytic disease of the newborn.
- Drugs — certain drugs such as penicillin can trigger the body to produce antibodies directed against RBCs or cause the direct destruction of RBCs.
- Physical destruction of RBCs by, for example, an artificial heart valve or cardiac bypass machine used during open-heart surgery
- Paroxysmal nocturnal haemoglobinurina (PNH) — a rare condition in which the different types of blood cells including RBCs, WBCs and platelets are abnormal. Because the RBCs are defective, they are destroyed by the body earlier than the normal lifespan. As the name suggests, people with this disorder can have acute, recurring episodes in which many RBCs are destroyed. This disease occurs due to a change or mutation in a gene called PIGA in the stem cells that make blood. Though it is a genetic disorder, it is not passed from one generation to the next (it is not an inherited condition). Patients will often pass dark urine due to the haemoglobin released by destroyed RBCs being cleared from the body by the kidneys. This is most noticeable first thing in the morning when urine is most concentrated. Episodes are thought to be brought on when the body is under stress during illnesses or after physical exertion. For more on this, see the Genetic Home Reference webpage.
These types of haemolytic anaemias are often first identified by signs and symptoms, during physical examination and by medical history. A medical history can reveal, for example, a recent transfusion, treatment with penicillin, or cardiac surgery. A FBC and/or blood film may show various abnormal results. Depending on those findings, additional follow-up tests may be performed. Some of these may include:
- Tests for autoantibodies for suspected autoimmune disorders
- Direct antiglobulin test (DAT) in the case of transfusion reaction, mother-baby blood type incompatibility, or autoimmune haemolytic anaemia
- Haptoglobin
- Reticulocyte count
Treatments for haemolytic anaemia are as varied as the causes. However, the goals are the same: to treat the underlying cause of the anaemia, to decrease or stop the destruction of RBCs, and to increase the RBC count and/or haemoglobin level to alleviate symptoms. This may involve, for example:
- Drugs used to decrease production of autoantibodies that destroy RBCs
- Blood transfusions to increase the number of healthy RBCs
- Bone marrow transplant — to increase production of normal RBCs
- Avoiding triggers that cause the anaemia such as the cold in some forms of autoimmune haemolytic anaemia or fava beans for those with G6PD deficiency.
Anaemia of chronic disease
Chronic (long-term) illnesses can cause anaemia. Often, anaemia caused by chronic diseases goes undetected until a routine test such as a full blood count reveals abnormal results. Several follow-up tests may be used to determine the underlying cause. There are many chronic conditions and diseases that can result in anaemia. Some examples of these include:
- Kidney disease — red blood cells are produced by the bone marrow in response to a hormone called erythropoietin, made primarily by the kidneys. Chronic kidney disease can cause anaemia resulting from too little production of this hormone; the anaemia can be treated by giving erythropoietin injections.
- Inflammatory conditions — whenever there are chronic diseases that stimulate the body’s inflammatory system, the ability of the bone marrow to respond to erythropoietin is decreased. For example, rheumatoid arthritis (a severe form of joint disease caused by the body attacking its own joints, termed an autoimmune disease) can cause anaemia by this mechanism.
- Other diseases that can produce anaemia in the same way as inflammatory conditions include chronic infections (such as with HIV or tuberculosis (TB), cancer and cirrhosis.
A number of tests may be used as follow up to abnormal results of initial tests such as a full blood count and blood film examination to determine the underlying cause of chronic anaemia. Some of these may include:
- Reticulocyte count
- Serum transferrin receptor can assist with the differentiation between iron deficiency anaemia and anaemia of chronic disease. (Serum ferritin may be elevated due to acute phase reactants even when the patient is iron deficient).
- E/LFT
- Tests for inflammation such as CRP
- Erythropoietin
- Tests for infections such as HIV and TB.
Treatment of anaemia due to chronic conditions usually involves determining and/or resolving the underlying disease. Blood transfusions may be used to treat the condition in the short term.
Aplastic anaemia
Aplastic anaemia is a rare disease, caused by a decrease in the number of all types of blood cells produced by the bone marrow. Normally, the bone marrow produces a sufficient number of new red blood cells (RBCs), white blood cells (WBCs) and platelets for normal body function. Each type of cell enters the blood stream, circulates and then dies within a certain time frame. For example, the normal lifespan of RBCs is about 120 days. If the bone marrow is not able to produce enough blood cells to replace those that die, a number of symptoms, including those due to anaemia, may result.
Symptoms of aplastic anaemia can appear abruptly or can develop more slowly. Some general symptoms that are common to different types of anaemia may appear first and are due to the decrease in number of RBCs. These include:
- feeling of tiredness, fatigue
- lack of energy
Some additional signs and symptoms that occur with aplastic anaemia include those due to decreased platelets:
- prolonged bleeding
- frequent nosebleeds
- bleeding gums
- easy bruising
and due to a low white blood cell count (WBC):
- increased number and severity of infections
Causes of aplastic anaemia usually have to do with damage to the stem cells in the bone marrow that are responsible for blood cell production. Some factors that may be involved with bone marrow damage and that can lead to aplastic anaemia include:
- exposure to toxic substances such as arsenic, benzene or pesticides
- cancer therapy (radiation or chemotherapy)
- autoimmune disorders such as lupus or rheumatoid arthritis
- viral infections such as hepatitis, EBV, HIV, CMV, or parvovirus B19
Rarely, aplastic anaemia is due to an inherited (genetic) disorder such as Fanconi anaemia. For more on this condition, see the Faconi Anemia Research Fund.
Laboratory tests
The initial test for anaemia, the full blood count (FBC), may reveal many abnormal results.
- Haemoglobin and/or haematocrit may be low.
- RBC and WBC counts are low.
- Platelet count is low.
- Red blood cell indices are usually normal.
- The differential white blood count shows a decrease in most types of cells but not lymphocytes.
Some additional tests that may be performed to help determine the type and cause of anemia include:
- Reticulocyte count — result is usually low.
- Erythropoietin — usually increased in aplastic anaemia.
- A bone marrow aspiration will show a decrease in the number of all types of mature cells.
- Tests for infections such as hepatitis, EBV, CMV, parvovirus B19 help to determine the cause.
- Test for arsenic (a heavy metal) and other toxins
- Iron tests or tests for vitamin B12 may be done to rule out other causes.
- Antibody tests such as ANA to determine if the cause is autoimmune disease.
A physical examination or complete medical history may reveal possible causes for aplastic anaemia such as exposure to toxins or certain drugs (for example, chloramphenicol) or prior treatment for cancer. Some cases of aplastic anaemia are temporary while others have lasting damage to the bone marrow. Treatment depends on the cause. Reducing or eliminating exposure to certain toxins or drugs may help resolve the condition. Medications may be given to stimulate bone marrow production, to treat infections or to suppress the immune system in cases of autoimmune disorders. Blood transfusions and a bone marrow transplant may be needed in severe cases.
Haemolytic anaemia
Rarely, anaemia is due to problems that cause the red blood cells (RBCs) to die or be destroyed prematurely. Normally, red cells live in the blood for about 4 months. In haemolytic anaemia, this time is shortened, sometimes to only a few days. The bone marrow is not able to produce new RBCs quickly enough to replace those that have been destroyed, leading to a decreased number of RBCs in the blood, which in turn leads to a diminished capacity to supply oxygen to tissues throughout the body. This results in the typical symptoms of anaemia including:
- weakness and/or fatigue
- lack of energy
- Depending on the cause, different forms of haemolytic anaemia can be chronic, developing and lasting over a long period or lifetime, or may be acute. The various forms can have a wide range of signs and symptoms.
See the discussions of the various types below for more on this.
The different causes of haemolytic anaemia fall into two main categories:
- Inherited forms in which a gene or genes are passed from one generation to the next that result in abnormal RBCs or haemoglobin
- Acquired forms in which some factor other than inherited results in the early destruction of RBCs
Inherited haemolytic anaemia
Two of the most common causes of inherited haemolytic anaemia are sickle cell anaemia and thalassaemia:
- Sickle cell anaemia can cause minor difficulties as the ‘trait’ (when you carry one mutated gene from one of your parents), but severe clinical problems as the ‘disease’ (when you carry two mutated genes, one from each of your parents). The red blood cells are misshapen, unstable (leading to haemolysis) and can block blood vessels, causing pain and anaemia. Screening is usually done on newborns – particularly those of African descent. Sometimes screening is done prenatally on a sample of amniotic fluid. Follow-up tests for haemoglobin variants may be performed to confirm a diagnosis. Treatment is usually based on the type, frequency and severity of symptoms.
- Thalassemia is a hereditary abnormality of haemoglobin production and results in small red blood cells that resemble those seen in iron deficiency. In its most severe form, the red cells have a shortened life span. In milder forms, anaemia is usually mild or absent, and the disease may be detected by finding small blood cells on a routine FBC. This genetic disease is found frequently in people of Mediterranean, African and Asian heritage. The defect in production may involve one of two components of haemoglobin called the alpha and beta protein chains. The disease is defined as alpha thalassaemia or beta thalassaemia accordingly. The "beta minor" form (sometimes called beta thal trait, as with sickle cell) occurs when a person inherits half normal genes and half beta thalassemia genes. It causes a mild anaemia and no symptoms. The "beta major" form (due to inheriting two beta thalassaemia genes and also called Cooley’s anaemia) is more severe and may result in growth problems, jaundice, and severe anaemia.
Other less common types of inherited forms of haemolytic anaemia include:
- Hereditary spherocytosis — results in abnormally shaped RBCs that may be seen on a blood smear
- Hereditary elliptocytosis — another cause of abnormally shaped RBCs seen on a blood film examination
- Glucose-6-phospate dehydrogenase (G6PD) deficiency — G6PD is an enzyme that is necessary for RBC survival. Its deficiency may be diagnosed with a test for its activity.
- Pyruvate kinase deficiency — Pyruvate kinase is another enzyme important for RBC survival and its deficiency may also be diagnosed with a test for its activity.
Laboratory tests
Since some of these inherited forms may have mild symptoms, they may first be detected on a routine FBC and blood film examination, which can reveal various abnormal results that give clues as to the cause. Follow-up tests are then usually performed to make a diagnosis. Some of these include:
- Tests for haemoglobin variants such as haemoglobin electrophoresis
- DNA analysis — not routinely done but can be used to help diagnose haemoglobin variants, thalassaemia, and to determine carrier status.
- G6PD test — to detect deficiency in this enzyme
- Flow cytometry detection of abnormal or missing red cell membrane proteins — detects RBCs that are more fragile than normal, which may be found in hereditary spherocytosis.
These genetic disorders cannot be cured but often the symptoms resulting from the anaemia may be alleviated with treatment as necessary.
Acquired haemolytic anaemia
Some of the conditions or factors involved in acquired forms of haemolytic anaemia include:
- Autoimmune disorders — a condition in which the body produces antibodies against its own red blood cells. It is not understood why this may happen.
- Transfusion reaction — result of blood donor-recipient incompatibility. This occurs very rarely but when it does, it can have some serious complications. For more on this, see the Blood banking article.
- Mother-baby blood group incompatibility — may result in haemolytic disease of the newborn.
- Drugs — certain drugs such as penicillin can trigger the body to produce antibodies directed against RBCs or cause the direct destruction of RBCs.
- Physical destruction of RBCs by, for example, an artificial heart valve or cardiac bypass machine used during open-heart surgery
- Paroxysmal nocturnal haemoglobinurina (PNH) — a rare condition in which the different types of blood cells including RBCs, WBCs and platelets are abnormal. Because the RBCs are defective, they are destroyed by the body earlier than the normal lifespan. As the name suggests, people with this disorder can have acute, recurring episodes in which many RBCs are destroyed. This disease occurs due to a change or mutation in a gene called PIGA in the stem cells that make blood. Though it is a genetic disorder, it is not passed from one generation to the next (it is not an inherited condition). Patients will often pass dark urine due to the haemoglobin released by destroyed RBCs being cleared from the body by the kidneys. This is most noticeable first thing in the morning when urine is most concentrated. Episodes are thought to be brought on when the body is under stress during illnesses or after physical exertion. For more on this, see the Genetic Home Reference webpage.
These types of haemolytic anaemias are often first identified by signs and symptoms, during physical examination and by medical history. A medical history can reveal, for example, a recent transfusion, treatment with penicillin, or cardiac surgery. A FBC and/or blood film may show various abnormal results. Depending on those findings, additional follow-up tests may be performed. Some of these may include:
- Tests for autoantibodies for suspected autoimmune disorders
- Direct antiglobulin test (DAT) in the case of transfusion reaction, mother-baby blood type incompatibility, or autoimmune haemolytic anaemia
- Haptoglobin
- Reticulocyte count
Treatments for haemolytic anaemia are as varied as the causes. However, the goals are the same: to treat the underlying cause of the anaemia, to decrease or stop the destruction of RBCs, and to increase the RBC count and/or haemoglobin level to alleviate symptoms. This may involve, for example:
- Drugs used to decrease production of autoantibodies that destroy RBCs
- Blood transfusions to increase the number of healthy RBCs
- Bone marrow transplant — to increase production of normal RBCs
- Avoiding triggers that cause the anaemia such as the cold in some forms of autoimmune haemolytic anaemia or fava beans for those with G6PD deficiency.
Anaemia of chronic diseases
Chronic (long-term) illnesses can cause anaemia. Often, anaemia caused by chronic diseases goes undetected until a routine test such as a full blood count reveals abnormal results. Several follow-up tests may be used to determine the underlying cause. There are many chronic conditions and diseases that can result in anaemia. Some examples of these include:
- Kidney disease — red blood cells are produced by the bone marrow in response to a hormone called erythropoietin, made primarily by the kidneys. Chronic kidney disease can cause anaemia resulting from too little production of this hormone; the anaemia can be treated by giving erythropoietin injections.
- Inflammatory conditions — whenever there are chronic diseases that stimulate the body’s inflammatory system, the ability of the bone marrow to respond to erythropoietin is decreased. For example, rheumatoid arthritis (a severe form of joint disease caused by the body attacking its own joints, termed an autoimmune disease) can cause anaemia by this mechanism.
- Other diseases that can produce anaemia in the same way as inflammatory conditions include chronic infections (such as with HIV or tuberculosis (TB), cancer and cirrhosis.
A number of tests may be used as follow up to abnormal results of initial tests such as a full blood count and blood film examination to determine the underlying cause of chronic anaemia. Some of these may include:
- Reticulocyte count
- Serum transferrin receptor can assist with the differentiation between iron deficiency anaemia and anaemia of chronic disease. (Serum ferritin may be elevated due to acute phase reactants even when the patient is iron deficient).
- E/LFT
- Tests for inflammation such as CRP
- Erythropoietin
- Tests for infections such as HIV and TB.
Treatment of anaemia due to chronic conditions usually involves determining and/or resolving the underlying disease. Blood transfusions may be used to treat the condition in the short term.
Last Updated: Thursday, 1st June 2023